Stimac, R.; Kerek, F.; Apell, H. J.: Macrocyclic carbon suboxide oligomers as potent inhibitors of the Na,K-ATPase. Annals of the New York Academy of Sciences 986, pp. 327 - 329 (2003)

Stimac, R.; Kerek, F.; Apell, H. J.: Macrocyclic carbon suboxide oligomers as potent inhibitors of the Na,K-ATPase. Annals of the New York Academy of Sciences 986, pp. 327 - 329 (2003)

Tejeda, M.; Gaal, D.; Csuka, O.; Ullrich, A.; Schwab, R.; Pap, A.; Horvath, A.; Keri, G.: The antitumor effect of the somatostatin analogue TT-232 depends on the treatment regimen. Cancer Detection and Prevention 27 (2), pp. 155 - 162 (2003)

Titze, J.; Schneider, M.; Krause, H.; Jacobi, J.; Stolte, M.; Linke, R. P.; Rupprecht, H. D.: Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case. Nephrology Dialysis Transplantation 18 (1), pp. 192 - 194 (2003)

Volpicella, M.; Ceci, L. R.; Cordewener, J.; America, T.; Gallerani, R.; Bode, W.; Jongsma, M. A.; Beekwilder, J.: Properties of purified gut trypsin from Helicoverpa zea, adapted to proteinase inhibitors. European Journal of Biochemistry 270 (1), pp. 10 - 19 (2003)

Zischka, H.; Keller, H.; Kellermann, J.; Eckerskorn, C.; Schuster, S. C.: Proteome analysis of the thermoreceptive pit membrane of the western diamondback rattlesnake Crotalus atrox. Proteomics 3 (1), pp. 78 - 86 (2003)

Hink-Schauer, C.; Estebanez-Perpina, E.; Wilharm, E.; Fuentes-Prior, P.; Klinkert, W.; Bode, W.; Jenne, D. E.: The 2.2-angstrom crystal structure of human pro-granzyme K reveals a rigid zymogen with unusual features. Journal of Biological Chemistry 277 (52), pp. 50923 - 50933 (2002)

Frey, H. G.; Keilmann, F.; Kriele, A.; Guckenberger, R.: Enhancing the resolution of scanning near-field optical microscopy by a metal tip grown on an aperture probe. Applied Physics Letters 81 (26), pp. 5030 - 5032 (2002)

Kerek, F.; Stimac, R.; Apell, H. J.; Freudenmann, F.; Moroder, L.: Characterization of the macrocyclic carbon suboxide factors as potent Na,K-ATPase and SR Ca-ATPase inhibitors. Biochimica et Biophysica Acta-Biomembranes 1567 (1-2), pp. 213 - 220 (2002)

Kerek, F.; Stimac, R.; Apell, H. J.; Freudenmann, F.; Moroder, L.: Characterization of the macrocyclic carbon suboxide factors as potent Na,K-ATPase and SR Ca-ATPase inhibitors. Biochimica et Biophysica Acta-Biomembranes 1567 (1-2), pp. 213 - 220 (2002)

Kue, P. F.; Taub, J. S.; Harrington, L. B.; Polakiewicz, R. D.; Ullrich, A.; Daaka, Y.: Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. International Journal of Cancer 102 (6), pp. 572 - 579 (2002)

Wiberg, C.; Heinegard, D.; Wenglen, C.; Timpl, R.; Morgelin, M.: Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. Journal of Biological Chemistry 277 (51), pp. 49120 - 49126 (2002)

Kamionka, M.; Rehm, T.; Beisel, H. G.; Lang, K.; Engh, R. A.; Holak, T. A.: In silico and NMR identification of inhibitors of the IGF-I and IGF-binding protein-5 interaction. Journal of Medicinal Chemistry 45 (26), pp. 5655 - 5660 (2002)

Kim, J. S.; Groll, M.; Musiol, H.-J.; Behrendt, R.; Kaiser, M.; Moroder, L.; Huber, R.; Brandstetter, H.: Navigation inside a protease: Substrate selection and product exit in the tricorn protease from Thermoplasma acidophilum. Journal of Molecular Biology 324 (5), pp. 1041 - 1050 (2002)

Dobbek, H.; Gremer, L.; Kiefersauer, R.; Huber, R.; Meyer, O.: Catalysis at a dinuclear [CuSMo(==O)OH] cluster in a CO dehydrogenase resolved at 1.1-angstrom resolution. Proceedings of the National Academy of Sciences of the United States of America 99 (25), pp. 15971 - 15976 (2002)

Sakahira, H.; Breuer, P.; Hayer-Hartl, M. K.; Hartl, F. U.: Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 99 (Suppl. 4), pp. 16412 - 16418 (2002)

Smallwood, S.; Hövel, T.; Neubert, W. J.; Moyer, S. A.: Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology 304 (1), pp. 135 - 145 (2002)

Kreuger, J.; Matsumoto, T.; Vanwildemeersch, M.; Sasaki, T.; Timpl, R.; Claesson-Welsh, L.; Spillmann, D.; Lindahl, U.: Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO Journal 21 (23), pp. 6303 - 6311 (2002)

Kreuger, J.; Matsumoto, T.; Vanwildemeersch, M.; Sasaki, T.; Timpl, R.; Claesson-Welsh, L.; Spillmann, D.; Lindahl, U.: Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO Journal 21 (23), pp. 6303 - 6311 (2002)

Fourmy, D.; Escrieut, C.; Archer, E.; Gales, C.; Gigoux, V.; Maigret, B.; Moroder, L.; Silvente-Poirot, S.; Martinez, J.; Fehrentz, J. A. et al.; Pradayrol, L.: Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists. Pharmacology & Toxicology 91 (6), pp. 313 - 320 (2002)